Onyx Biotec

About the Company

Onyx Biotec Limited, established in 2005 and converted to a public company in 2024, specializes in manufacturing sterile pharmaceutical products like sterile water for injections and dry powder injections, serving top pharma clients across India and overseas. With two manufacturing facilities in Himachal Pradesh accredited by WHO-GMP, the company follows strict quality controls and sustainable practices. It plans to enhance Unit I for large-volume parental production and Unit II with a high-speed packaging line, improving operational efficiency and cost. Led by experienced promoters, Onyx is committed to delivering affordable, high-quality healthcare solutions, maintaining strong client relationships, and adhering to ISO and GMP standards to ensure quality, safety, and customer satisfaction.

Strengths

• Leading contract manufacturer specializing in sterile pharmaceutical production.
• Rigorous Quality Assurance and Quality Control processes ensure high product standards.
• Established, long-term relationships with top-tier clients in the pharmaceutical industry.
• Cost-efficient production processes with a focus on timely order fulfilment.
• Experienced management team with strong project management and implementation expertise.

Risks

• Region-specific risks in Solan, Himachal Pradesh could impact operations.
• Manufacturing disruptions could harm financial health and cash flow.
• Reliance on third-party suppliers risks supply delays or shortages.
• Heavy dependence on key clients makes revenue vulnerable to client loss.
• Pharmaceutical industry downturns could reduce demand for products.
• Quality or delivery issues may lead to order cancellations and financial loss.